Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mackenzie J Thurston

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Neurobiology of Disease|January 25, 2020
Immunotherapy for Parkinson's diseaseAaron D Schwab, Mackenzie J Thurston, Jatin Machhi, et al.
Ebiomedicine|May 17, 2021
Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's diseaseKatherine E Olson, Krista L Namminga, Yaman Lu, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 9, 2020
Neuroprotective Activities of Long-Acting Granulocyte-Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated MiceKatherine E Olson, Krista L Namminga, Aaron D Schwab, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 8, 2019
Axonal damage in spinal cord is associated with gray matter atrophy in sensorimotor cortex in experimental autoimmune encephalomyelitisCassandra E Meyer, Josephine L Gao, James Ying-Jie Cheng, et al.
Biomaterials|April 11, 2021
Granulocyte-macrophage colony-stimulating factor mRNA and Neuroprotective Immunity in Parkinson's diseaseKatherine E Olson, Krista L Namminga, Yaman Lu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Neurobiology of Disease|January 25, 2020
Immunotherapy for Parkinson's diseaseAaron D Schwab, Mackenzie J Thurston, Jatin Machhi, et al.
Ebiomedicine|May 17, 2021
Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's diseaseKatherine E Olson, Krista L Namminga, Yaman Lu, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 9, 2020
Neuroprotective Activities of Long-Acting Granulocyte-Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated MiceKatherine E Olson, Krista L Namminga, Aaron D Schwab, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 8, 2019
Axonal damage in spinal cord is associated with gray matter atrophy in sensorimotor cortex in experimental autoimmune encephalomyelitisCassandra E Meyer, Josephine L Gao, James Ying-Jie Cheng, et al.
Biomaterials|April 11, 2021
Granulocyte-macrophage colony-stimulating factor mRNA and Neuroprotective Immunity in Parkinson's diseaseKatherine E Olson, Krista L Namminga, Yaman Lu, et al.
Pageof 1